Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes. 2002

Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
Department of Biochemistry, Faculty of Medicine, National University of, Singapore, Singapore 119260.

Several snake venoms contain proteinases that activate zymogens in the coagulation cascade and thus exhibit their procoagulant effects. While most procoagulant proteinases from snake venoms are dissimilar to coagulation factors, Group D (trocarin, notecarin) and C (pseutarin) prothrombin activators are structural and functional homologues of factor Xa and the prothrombinase complex, respectively. We examined the effect of these and other procoagulants from snake venoms as well as mammalian and snake thromboplastins on the coagulation of plasmas of Notechis scutatus, Pseudonaja textilis (both procoagulant venoms), Python reticulatus (non-venomous) and Crotalus atrox (non-procoagulant venom) snakes. The results indicate that the intrinsic pathway seems to be weak or absent only in venomous snakes, while the extrinsic pathway is fully functional in all snakes. Python and Crotalus plasmas have extrinsic pathways similar to that in mammals. In contrast, although Notechis and Pseudonaja plasmas were clotted by a Group C activator, they failed to clot upon the addition of factor Xa and Group D activators. The mechanism of this resistance is still elusive.

UI MeSH Term Description Entries
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003029 Coagulants Agents that cause clotting. Coagulant
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012910 Snake Venoms Solutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands (Duvernoy's gland) for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors. Duvernoy's Gland Secretion,Duvernoy's Secretion,Snake Toxin,Snake Toxins,Snake Venom,Duvernoy Gland Secretion,Duvernoy Secretion,Duvernoys Gland Secretion,Duvernoys Secretion,Secretion, Duvernoy's,Secretion, Duvernoy's Gland,Toxin, Snake,Venom, Snake
D012911 Snakes Limbless REPTILES of the suborder Serpentes. Serpentes,Ophidia,Snake
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine

Related Publications

Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
June 1979, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
April 1966, Problemy gematologii i perelivaniia krovi,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
May 2002, Toxicon : official journal of the International Society on Toxinology,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
January 1985, Pharmacology & therapeutics,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
July 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
May 2005, Herz,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
September 1951, Doklady Akademii nauk SSSR,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
March 1959, Arztliche Forschung,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
January 1960, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Jeremiah S Joseph, and Maxey C M Chung, and Peter J Mirtschin, and R Manjunatha Kini
January 1955, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
Copied contents to your clipboard!